Requires NJT to establish pilot program to supply certain light rail train sets with opioid antidotes; makes appropriation of $100,000.

This bill requires New Jersey Transit (NJT) to create a two-year pilot program equipping light rail trains operating in southern New Jersey with opioid antidotes (like naloxone). It mandates secure storage with silent alerts to notify operators of potential overdoses, two doses per train, multilingual signage, and informational cards - without requiring staff to administer the antidote or undergo specialized training. NJT must maintain records and report on the program's effectiveness to the Governor and Legislature within six months of the pilot's end, using a $100,000 state appropriation. The program directly affects NJT staff and passengers on southern light rail routes, aiming to provide rapid response to opioid overdoses during transit.